Kent Lewandrowski

Kent Lewandrowski, MD serves as a Professor of Pathology at Harvard Medical School and works as a Pathologist at Massachusetts General Hospital where he holds the position of Associate Chief for Laboratory and Molecular Medicine. His clinical practice focuses on adult patients with specialties in Clinical Pathology and Point of Care Testing.

Dr. Lewandrowski completed his medical education at UMASS Medical School followed by residency training at Massachusetts General Hospital. He is board certified in Anatomic and Clinical Pathology by the American Board of Pathology.

His primary research interests center on point-of-care diagnostics development and validation, with specific expertise in serum cardiac markers. He maintains an active research program investigating pancreatic pathology, including chemical and histopathologic features of pancreatic neoplasms and the pathology of acute experimental pancreatitis. His publication record demonstrates expertise in laboratory medicine applications for clinical diagnostics, particularly in point-of-care testing systems validation and kidney function monitoring.

As Associate Chief for Laboratory and Molecular Medicine, Dr. Lewandrowski is affiliated with the Mass General Brigham Personalized Medicine division, which includes the Laboratory for Molecular Medicine located at 65 Landsdowne Street in Cambridge. This organization provides genomic and molecular diagnostic services while advancing research in personalized medicine approaches.